Results of 2023 survey on the use of synthetic computed tomography for magnetic resonance Imaging-only radiotherapy: Current status and future steps.

ABSTRACT:

Background and purpose

The emergence of synthetic CT (sCT) in MR-guided radiotherapy (MRgRT) represents a significant advancement, supporting MR-only workflows and online treatment adaptation. However, the lack of consensus guidelines has led to varied practices. This study reports results from a 2023 ESTRO survey aimed at defining current practices in sCT development and use.

Materials and methods

An survey was distributed to ESTRO members, including 98 questions across four sections on sCT algorithm generation and usage. By June 2023, 100 centers participated. The survey revealed diverse clinical experiences and roles, with primary sCT use in the pelvis (60%), brain (15%), abdomen (11%), thorax (8%), and head-and-neck (6%). sCT was mostly used for conventional fractionatio

SUBMITTER: Fusella M 

PROVIDER: S-EPMC11460247 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature